IVA vs SNY
Inventiva S.a. and Sanofi, side by side — 7 fiscal years reported in EUR, drawn from SEC filings.
Most recent reported year
| Metric | IVA | SNY |
|---|---|---|
| Revenue | €9.2M | €43.6B |
| Net income | €-184.2M | €7.8B |
| Gross margin | · | 77.2% |
| Net margin | · | 18.0% |
| Return on equity | · | 10.5% |
| Diluted EPS | −€3.08 | €6.37 |
| Dividend / share | · | €3.92 |
| Payout ratio | · | 61.1% |
| Free cash flow | · | · |
| Equity | · | €71.4B |
| Net debt / equity | · | 0.15× |
| Current ratio | 0.92× | 1.09× |
| Revenue CAGR 5y | 5.6% | 3.9% |
| Profit CAGR 5y | · | −8.7% |
SNY bills 4743.0× the revenue of IVA, and IVA closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | IVA | SNY |
|---|---|---|
| FY2024 | €9.2M | €41.1B |
| FY2023 | €17.5M | €37.8B |
| FY2022 | €12.2M | €37.7B |
| FY2021 | €4.2M | €37.8B |
| FY2020 | €372,000 | €36.0B |
| FY2019 | €7.0M | €36.1B |
| FY2018 | €3.2M | €34.5B |
Bottom line
| Fiscal year | IVA | SNY |
|---|---|---|
| FY2024 | €-184.2M | €5.6B |
| FY2023 | €-110.4M | €5.4B |
| FY2022 | €-54.3M | €8.4B |
| FY2021 | €-49.6M | €6.2B |
| FY2020 | €-33.6M | €12.3B |
| FY2019 | €-30.2M | €2.8B |
| FY2018 | €-33.0M | €4.3B |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | −€41,071,802,000 | SNY |
| FY2023 | −€37,799,523,000 | SNY |
| FY2022 | −€37,638,821,000 | SNY |
| FY2021 | −€37,756,806,000 | SNY |
| FY2020 | −€36,040,628,000 | SNY |
| FY2019 | −€36,119,002,000 | SNY |
| FY2018 | −€34,459,803,000 | SNY |
SNY has reported the higher revenue in every one of these 7 fiscal years. The gap has widened since the earliest year compared.
7 of 11 comparable fiscal years — a year missing data on either side is not counted.
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2023 | −646.2 pp | SNY |
| FY2022 | −468.2 pp | SNY |
| FY2021 | −1200.1 pp | SNY |
| FY2019 | −439.5 pp | SNY |
| FY2018 | −1045.5 pp | SNY |
SNY has kept the higher net margin in every one of these 5 fiscal years.
5 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
IVA's net margin has been more volatile than SNY's over the 5 comparable fiscal years — 308.4 percentage points of standard deviation against 4.9.
5 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
SNY led in net margin in every one of the 5 comparable fiscal years — a structural lead, not a recent swing.
5 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
IVA's return on equity has been more volatile than SNY's over the 5 comparable fiscal years — 12.7 percentage points of standard deviation against 5.3.
5 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
SNY led in return on equity in every one of the 5 comparable fiscal years — a structural lead, not a recent swing.
5 of 11 comparable fiscal years — a year missing data on either side is not counted.